sulfobromophthalein has been researched along with Insulin Resistance in 1 studies
Sulfobromophthalein: A phenolphthalein that is used as a diagnostic aid in hepatic function determination.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Kharashi, OA | 1 |
| El-Din Aly El-Waseef, DA | 1 |
| Nabih, ES | 1 |
| Mohamed, DI | 1 |
1 other study available for sulfobromophthalein and Insulin Resistance
| Article | Year |
|---|---|
Targeting NLRP3 inflammasome via acetylsalicylic acid: Role in suppressing hepatic dysfunction and insulin resistance induced by atorvastatin in naïve versus alcoholic liver in rats.
Topics: Alcoholism; Animals; Aspirin; Atorvastatin; Bile Acids and Salts; Caspase 8; Hepatocytes; Inflammaso | 2018 |